Home
Arena Pharmaceuticals, Inc.

Arena Pharmaceuticals, Inc. Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domainarenapharm.com

Year Founded1997

Employees201 - 500

Annual Revenue> $1B

Arena Pharmaceuticals, Inc.

Arena Pharmaceuticals, Inc. (including company regionals)

arenapharm.com

See more website traffic and engagement information

Arena Pharmaceuticals, Inc. Revenue up to June 2026 is > 1B

revenue generated by Arena Pharmaceuticals, Inc. top domains

Arena Pharmaceuticals, Inc. top domains revenue over 3 years

Revenue for Arena Pharmaceuticals, Inc. top domains

arenapharm.com> 1B

See more with Sales Intelligence

Total visits to Arena Pharmaceuticals, Inc.'s top domains

Understand Arena Pharmaceuticals, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Arena Pharmaceuticals, Inc.'s top domains

Analyze Arena Pharmaceuticals, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Arena Pharmaceuticals, Inc.'s top domains

See how Arena Pharmaceuticals, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Arena Pharmaceuticals, Inc. top competitors by domain

Top similar sites in June 2026, ranked by their affinity

halozyme.comCompany NameHalozymeEmployees201 - 500HQUnited States, California, San DiegoAnnual revenue> $1BTotal visits9.8KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Arena Pharmaceuticals, Inc.

These are the website technologies, by industry, used by Arena Pharmaceuticals, Inc. top domains

Widget (3)

Twemoji

Advertising (2)

DoubleClick

Content Management System (2)

WordPress

Marketing (2)

Google Marketing Platform

More Technologies

9

See all

News & Signals from Arena Pharmaceuticals, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsArenapharm launched Dostarlimab on May 1st '23.In May 2023, Arena Pharmaceuticals launched Dostarlimab, an immunotherapy for the treatment of advanced endometrial cancer.

NewsPfizer, Inc. acquired Arenapharm for $6.7B on Jan 1st '22.Etrasimod was developed by Arena Pharmaceuticals, which was acquired by Pfizer in 2022.

NewsPfizer acquired Arenapharm for $6.7B on Dec 22nd '22.Etrasimod was developed by Arena Pharmaceuticals, which was acquired by Pfizer earlier this year.